Cargando…
Imaging of Claudin-4 in Pancreatic Ductal Adenocarcinoma Using a Radiolabelled Anti-Claudin-4 Monoclonal Antibody
PURPOSE: Despite its widespread use, the positron emission tomography (PET) radiotracer 2-deoxy-2-[(18)F]fluoro-D-glucose ([(18)F]FDG) has been shown in clinical settings to be ineffective for improving early diagnosis of pancreatic ductal adenocarcinoma (PDAC). A promising biomarker for PDAC detect...
Autores principales: | Torres, Julia Baguña, Knight, James C., Mosley, Michael J., Kersemans, Veerle, Koustoulidou, Sofia, Allen, Danny, Kinchesh, Paul, Smart, Sean, Cornelissen, Bart |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5862916/ https://www.ncbi.nlm.nih.gov/pubmed/28842811 http://dx.doi.org/10.1007/s11307-017-1112-8 |
Ejemplares similares
-
Radiolabeled cCPE Peptides for SPECT Imaging of Claudin-4 Overexpression in Pancreatic Cancer
por: Torres, Julia Baguña, et al.
Publicado: (2020) -
Dual-isotope imaging allows in vivo immunohistochemistry using radiolabelled antibodies in tumours()()
por: Knight, James C., et al.
Publicado: (2019) -
Immunoexpression of Claudin 4 in Gastric Adenocarcinomas
por: CREȚU, OANA IULIA, et al.
Publicado: (2022) -
Tumor Imaging Using Radiolabeled Matrix Metalloproteinase–Activated Anthrax Proteins
por: Elvina Xavier, Mary-Ann, et al.
Publicado: (2019) -
Targeting claudin‐4 enhances chemosensitivity of pancreatic ductal carcinomas
por: Sasaki, Takamitsu, et al.
Publicado: (2019)